Mitarai, Sayaka, Thomas D. Reed, and Atsuko Yatani. Changes in ionic currents and ␤-adrenergic receptor signaling in hypertrophied myocytes overexpressing G␣ q . Am J Physiol Heart Circ Physiol 279: H139-H148, 2000.-Transgenic overexpression of G␣ q causes cardiac hypertrophy and depressed contractile responses to ␤-adrenergic receptor agonists. The electrophysiological basis of the altered myocardial function was examined in left ventricular myocytes isolated from transgenic (G␣ q ) mice. Action potential duration was significantly prolonged in G␣ q compared with nontransgenic (NTG) myocytes. The densities of inward rectifier K ϩ currents, transient outward K ϩ currents (I to ), and Na ϩ /Ca 2ϩ exchange currents were reduced in G␣ q myocytes. Consistent with functional measurements, Na ϩ /Ca 2ϩ exchanger gene expression was reduced in G␣ q hearts. Kinetics or sensitivity of I to to 4-aminopyridine was unchanged, but 4-aminopyridine prolonged the action potential more in G␣ q myocytes. Isoproterenol increased L-type Ca 2ϩ currents (I Ca ) in both groups, with a similar EC 50 , but the maximal response in G␣ q myocytes was ϳ24% of that in NTG myocytes. In NTG myocytes, the maximal increase of I Ca with isoproterenol or forskolin was similar. In G␣ q myocytes, forskolin was more effective and enhanced I Ca up to ϳ55% of that in NTG myocytes. These results indicate that the changes in ionic currents and multiple defects in the ␤-adrenergic receptor/ Ca 2ϩ channel signaling pathway contribute to altered ventricular function in this model of cardiac hypertrophy. action potential; potassium currents; sodium-calcium exchanger; calcium currents; heart failure; transgenic model MYOCARDIAL HYPERTROPHY is an initial adaptive process to a variety of physiological and pathological conditions associated with increased cardiac work. The hypertrophic response initially normalizes wall stress and maintains ventricular function. However, decompensated congestive heart failure occurs when the adaptive process fails. The molecular mechanisms that trigger cardiac hypertrophy and regulate the progression to heart failure have not been well elucidated (7). Results from recent studies in transgenic mice indicate that stimulation of the signal transduction pathways mediated by heterotrimeric G q protein is closely re-
action potential; potassium currents; sodium-calcium exchanger; calcium currents; heart failure; transgenic model MYOCARDIAL HYPERTROPHY is an initial adaptive process to a variety of physiological and pathological conditions associated with increased cardiac work. The hypertrophic response initially normalizes wall stress and maintains ventricular function. However, decompensated congestive heart failure occurs when the adaptive process fails. The molecular mechanisms that trigger cardiac hypertrophy and regulate the progression to heart failure have not been well elucidated (7) . Results from recent studies in transgenic mice indicate that stimulation of the signal transduction pathways mediated by heterotrimeric G q protein is closely related to the induction of cardiac hypertrophy and its progression to heart failure (1, 2, 8, 20, 23) .
In ventricular myocytes isolated from failing human hearts, the magnitude of contraction is diminished and relaxation is prolonged. These changes are associated with changes in electrophysiological properties and abnormal intracellular Ca 2ϩ handling (3, 4, 11) . Prolongation of the action potential is the most consistently observed electrophysiological abnormality in failing human hearts. Downregulation of the repolarizing K ϩ currents, the inward rectifier K ϩ currents (I K1 ) and the transient outward K ϩ currents (I to ), has been postulated to underlie the observed action potential prolongation (5) . Molecular and biochemical studies in failing human hearts indicate that altered expression of the sarcoplasmic reticulum (SR) Ca 2ϩ regulatory proteins, such as SR Ca 2ϩ -ATPase and phospholamban, may contribute to altered intracellular Ca 2ϩ transients (10, 12, 16, 21) . Upregulation of the sarcolemmal Na ϩ /Ca 2ϩ exchanger has also been suggested as a compensatory mechanism for decreased SR Ca 2ϩ uptake (9, 22) . Another hallmark of human heart failure is depressed contractile responsiveness to catecholamines. Multiple changes in the ␤-adrenergic receptor (␤-AR) signaling pathway, including changes in ␤-AR expression (a selective loss of ␤ 1 -ARs) and G protein activity levels [inhibitory G protein (G i ) and/or stimulatory G protein (G s )], increased ␤-AR kinase levels, impaired ␤-AR/adenylyl cyclase coupling, and decreased adenylyl cyclase activity, occur in the failing human heart (13) . However, most studies in human hearts are limited to a single time point, usually in hearts with severe hypertrophy or terminal heart failure, and the relationships between the degree of ventricular dysfunction and cellular abnormalities are not well characterized.
In this regard, a transgenic mouse model, overexpressing the ␣-subunit of G q in the heart, which reproduces many biochemical and hemodynamic changes seen in human heart disease, may provide an informative model system to investigate the cellular mechanisms of cardiac hypertrophy and failure (8, 23) . For example, at higher levels of G␣ q overexpression (5-fold over endogenous levels), frank cardiac decompensation occurs, with development of biventricular failure, pulmonary congestion, and death between 11 and 14 wk of age (8) . Twofold overexpression of G␣ q shows no detectable effects on cardiac gene expression, function, or hypertrophy, suggesting that a threshold level of G␣ q expression is necessary to transduce these effects. By contrast, relatively modest (ϳ4-fold) overexpression of G␣ q (G␣ q-25 ) results in moderate cardiac hypertrophy and increased hypertrophy-associated gene expression. Echocardiography and in vivo cardiac hemodynamic studies revealed significantly impaired intrinsic contractility and responses to ␤-AR agonists. Nevertheless, G␣ q-25 mice exhibit relatively compensated left ventricular function. These mice have a normal life span and do not develop overt heart failure. Thus G␣ q-25 mice provide an intermediate-phase cardiac hypertrophy model, neither fully compensated nor decompensated, that has been designated previously as "compromised" heart (23) .
Recently, we reported that left ventricular myocytes isolated from transgenic G␣ q-25 (G␣ q ) mice exhibit prolonged contractions and Ca 2ϩ transients associated with reductions in Ca 2ϩ uptake rates and the apparent affinity of SR Ca 2ϩ -ATPase for Ca 2ϩ (30) . There was no change in L-type Ca 2ϩ current (I Ca ) density. If impaired Ca 2ϩ uptake by the SR were the only cellular abnormality, then significantly decreased amplitude of contractions and Ca 2ϩ transients should be observed in G␣ q myocytes. However, we found no such differences, suggesting that other Ca 2ϩ regulatory mechanisms may be involved in the abnormal Ca 2ϩ signaling observed in G␣ q myocytes.
The most consistent electrophysiological change in a variety of experimental models as well as in human heart failure is action potential prolongation. Prolongation of the action potential may have a profound effect on cellular excitation-contraction coupling. Because a normal action potential is the result of an orderly sequence of changes in the permeability of the membrane inward and outward ionic currents, the delayed repolarization can occur secondary to an increase in the inward currents, a decrease in the outward currents, and/or more complex changes generated by the sarcolemmal Na ϩ /Ca 2ϩ exchanger. Accordingly, we examined electrophysiological parameters such as action potentials, K ϩ channel currents, and Na ϩ /Ca 2ϩ exchange currents in left ventricular myocytes isolated from G␣ q and nontransgenic (NTG) control mice. In addition, because the cardiac Ca 2ϩ channel is a well-characterized physiological effector of ␤-AR signal transduction, we examined the effects of isoproterenol (Iso) to identify cellular mechanisms related to ␤-AR dysfunction.
MATERIALS AND METHODS
Generation of transgenic mice. Transgenic (G␣ q ) mice with a nearly fourfold increase of the murine ␣-subunit of G q in the heart (G␣ q-25 ) were generated as previously described (8) . The mice overexpressing moderate levels of G␣ q do not exhibit cardiomyocyte replacement or apoptotic heart failure at the age (12-15 wk) used in the present studies (1) .
Preparation of myocytes. Cardiac myocytes from 14 G␣ q mice and 14 control NTG littermates were used for electrophysiolgical measurements. Single left ventricular myocytes were isolated from the hearts of NTG and G␣ q mice by a method described previously (19) . Briefly, the heart was perfused with Ca 2ϩ -free Tyrode solution containing collagenase (type II, 0.5 mg/ml; Worthington) and BSA (1 mg/ml) for 10-20 min by the Langendorff method at 37°C. At the end of the perfusion period, the heart was removed, myocytes were prepared from the apical two-thirds of the left ventricle, and these myocytes were passed through 200-m nylon mesh. In some experiments, atrial myocytes were prepared (18) and used to test the ability of pertussis toxin (PTX) to block muscarinic receptor-mediated activation of K ϩ channel currents. The isolated cells were stored in low-Cl Ϫ , high-K ϩ medium, and all experiments were performed at room temperature (20-22°C).
The amount of myocyte hypertrophy as estimated by the cell membrane capacitance in the present experiments was comparable to that reported in previous studies of G␣ q myocytes (30) . Cell capacitance was 129.0 Ϯ 2.7 pF (n ϭ 120) in NTG and 146.1 Ϯ 3.9 pF (n ϭ 131) in G␣ q myocytes (P Ͻ 0.01).
Electrophysiology. Whole cell currents were recorded using patch-clamp techniques, as previously described (19) . Patch electrodes had 1.5-to 2.5-M⍀ tip resistance for whole cell current recordings and 10-to 15-M⍀ tip resistance for action potential measurements. Membrane capacitance was measured using voltage ramps of 0.8 V/s from a holding potential of Ϫ50 mV. The experimental chamber (0.2 ml) was placed on a microscope stage, and external solution changes were made rapidly using a modified Y-tube technique (29) .
For action potential and K ϩ current recordings, myocytes were perfused with normal Tyrode solution composed of (mM) 135 NaCl, 1. signaling. However, under these conditions, activation of cell contraction occurred frequently in the initial periods of cell dialysis, rendering stable recordings difficult. We therefore performed all K ϩ current measurements in the presence of 5 mM EGTA. The voltage dependence of I to inactivation was determined by applying 500-ms depolarizing pulses to different potentials (Ϫ100 and 0 mV) from a holding potential of Ϫ80 mV. The extent of activation was quantified by the peak current measured at ϩ40 mV. The prepulse inactivation curves were normalized to the maximum current fitted with a Boltzmann equation:
where I is current, I max is maximum current, V m is membrane potential, V 0.5 is midpotential, and k is the slope factor. Ca 2ϩ currents were recorded using an external solution containing (mM) 2 CaCl 2 , 1 MgCl 2 , 135 tetraethylammonium chloride, 5 4-aminopyridine (4-AP), 10 glucose, and 10 HEPES (pH 7.3). To determine responses to ␤-AR stimulation, myocytes were dialyzed with the pipette solution containing (mM) 100 cesium aspartate, 20 CsCl, 1 MgCl 2 , 2 MgATP, 0.5 GTP, 10 BAPTA, and 5 HEPES (pH 7.3). These solutions isolated I Ca from other membrane currents such as Na ϩ and K ϩ channel currents and also Ca 2ϩ flux through the Na ϩ /Ca 2ϩ exchanger. As we previously showed, ␤-AR regulation of the Ca 2ϩ channel can be reliably measured under these experimental conditions (25) . The voltage dependence of activation was determined using an interactive nonlinear regression fitting procedure to the Boltzmann equation: (15) . To activate Na ϩ /Ca 2ϩ exchange currents, the cells were held at Ϫ40 mV, and the external solution was rapidly switched to one in which equimolar LiCl was substituted for NaCl (15, 17) . Exposure of the myocytes to Na ϩ -free solution produced outward Na ϩ extrusion through the Na
RNase protection assay. Total RNA was isolated from the hearts of five G␣ q mice and five NTG littermates by use of the ULTRASPEC-II RNA Isolation System (Biotecx Laboratories, Houston, TX). The MAXIscript In Vitro Transcription Kit (Ambion, Austin, TX) was used to synthesize radiolabeled cRNA probes from linearized DNA riboprobe templates. The mouse Na ϩ /Ca 2ϩ exchanger (NCX-1) riboprobe template was prepared by subcloning an RT-PCR-generated cDNA fragment (spanning nucleotides Ϫ31 to ϩ118 bp relative to the AUG translational start codon) into pBluescript SK(ϩ). Gene expression levels were determined from total RNA samples by use of the RNase Protection Assay (RPA) Kit (Ambion). The RPA gel was dried and then exposed to BIOMAX-MR X-ray film (Kodak, New Haven, CT). Overall NCX-1 levels were determined by 1) exposing the RPA gel to a Kodak phosphor screen, 2) scanning signal levels with a PhosphorImager (Molecular Dynamics, Wayzata, MN), and 3) analyzing the data with NIH Image Analysis software.
Values are means Ϯ SE. Comparisons between conditions were evaluated using the Student's t-test, with significance imparted at P Ͻ 0.05.
RESULTS
Action potential. Action potentials (Fig. 1) were recorded in control NTG and G␣ q left ventricular myocytes in Tyrode solution with physiological pipette solution (see MATERIALS AND METHODS). NTG myocytes displayed a brief action potential with a rapid initial phase of repolarization without a discernible plateau phase. The shape and duration of the action potential recorded in NTG myocytes were similar to those observed in adult mouse ventricular myocytes reported previously (27, 31) . In contrast, the action potential recorded in G␣ q myocytes showed a relatively small initial notch followed by a clear plateau phase. Action potential duration quantified at 50 and 70% repolarization (APD 50 and APD 70 ) was significantly prolonged in G␣ q myocytes (Table 1 ). There was no significant difference in the resting membrane potentials between the two groups.
Action potential shape and duration are species specific because of differences in the underlying inward and outward currents. In adult mouse ventricular myocytes, the 4-AP-sensitive I to has been described to play an important role in the early and middle phase of the action potential (27, 31) , suggesting that changes in I to may contribute to the action potential prolongation observed in G␣ q myocytes. K ϩ channel currents. Figure 2 illustrates typical outward currents recorded in NTG (A) and G␣ q (B) myocytes. In both groups, depolarization positive to Ϫ30 mV activated outward currents, which then decayed slowly to a sustained outward current at the end of a 300-ms voltage step. Details of electrophysiological characteristics of the outward currents in adult mouse ventricular myocytes that exhibit a sum of fast and slow components have been described elsewhere (31) . In the present study, we refer to the total K ϩ current components simply as I to . Myocytes isolated from G␣ q hearts showed a smaller current amplitude than those from NTG hearts.
When the time course of inactivation was fit to a sum of the two (fast and slow) exponentials, fast ( f ) and slow ( s ) time constants and the relative amplitude [A f /(A f ϩ A s )] in G␣ q myocytes were comparable to those in NTG myocytes. The f , s , and A f /(A f ϩ A s ) at ϩ60 mV were 13.8 Ϯ 1.1 ms, 99.1 Ϯ 8.2 ms, and 0.48 Ϯ 0.02 for NTG (n ϭ 10) and 15.3 Ϯ 1.5 ms, 102.5 Ϯ 8.8 ms, and 0.46 Ϯ 0.02 for G␣ q (n ϭ 21) myocytes, respectively. The current-voltage (I-V) relationships of peak and sustained current amplitudes, normalized relative to cell capacitance (pA/pF), are plotted in Fig. 2C . The average current densities of peak and sustained components were significantly decreased in G␣ q myocytes. At ϩ60 mV, the peak and sustained currents were 25.4 Ϯ 1.1 and 13.0 Ϯ 0.8 pA/pF (n ϭ 52) for NTG and 17.8 Ϯ 1.4 and 10.0 Ϯ 0.8 pA/pF (n ϭ 46) for G␣ q myocytes. The voltage dependence of I to inactivation was similar between the two groups (Fig. 2D) . The mean values of V 0.5 and k were Ϫ41.9 Ϯ 0.9 mV and 6.4 Ϯ 1.1 mV for NTG myocytes (n ϭ 10) and Ϫ44.9 Ϯ 2.2 mV and 8.0 Ϯ 1.8 mV for G␣ q myocytes (n ϭ 7), respectively.
Peak and sustained currents were blocked by 4-AP (Fig. 3, A and B) . Cumulative concentration-response relationships revealed that IC 50 was similar between the two groups (Fig. 3C) .
To measure I K1 , hyperpolarizing pulses were applied from a holding potential of Ϫ40 mV to test potentials between Ϫ50 and Ϫ100 mV. Figure 4 shows representative I K1 recorded from NTG (A) and G␣ q (B) myocytes. The current was blocked by external application of 0.5 mM Ba 2ϩ (5) . G␣ q myocytes showed a significant reduction of the current density (Fig. 4C ). The mean current density at Ϫ100 mV was Ϫ12.1 Ϯ 0.9 and Ϫ7.2 Ϯ 0.9 pA/pF for NTG (n ϭ 22) and G␣ q (n ϭ 32) myocytes, respectively. Na ϩ /Ca 2ϩ exchange currents. The Na ϩ /Ca 2ϩ exchanger is the principal mechanism for Ca 2ϩ extrusion from the cell. However, it has been proposed that inward Na ϩ flux in exchange for Ca 2ϩ efflux via the Na ϩ /Ca 2ϩ exchanger can contribute to depolarizing current during the action potential plateau (6) . Therefore, Na 
NTG (A) and G␣q myocytes (B). When the external Na
ϩ was changed to Li ϩ , the membrane current shifted to an outward direction in both groups; however, peak current amplitude was significantly smaller in G␣ q myocytes. Under our experimental conditions, the average Na ϩ /Ca 2ϩ exchange current density in NTG and G␣ q myocytes was 0.76 Ϯ 0.1 (n ϭ 15) and 0.38 Ϯ 0.04 pA/pF (n ϭ 22), respectively (Fig. 5C) . Na ϩ /Ca 2ϩ exchanger gene expression. To determine whether the functional changes were associated with alterations in the Na ϩ /Ca 2ϩ exchanger gene expression, we used an RPA to quantify NCX-1 mRNA levels (Fig. 6) . Total RNA from the hearts of G␣ q mice and NTG littermates was hybridized with a riboprobe specific for the mouse NCX-1 transcript. The hybridization reactions were subjected to RNase treatment, electrophoresed, and visualized by autoradiography (Fig. 6A) . Overall NCX-1 expression levels were determined by exposing the RPA gel to a phosphor plate, scanning the plate with a PhosphorImager, and analyzing the results with NIH Image Analysis software. As summarized in Fig. 6C , NCX-1 mRNA levels were reduced by 40% in G␣ q hearts compared with NTG hearts. These changes could not be accounted for by changes in loading conditions (Fig. 6B) .
Contribution of I to to action potential prolongation. In an earlier study, we found that the time course of I Ca inactivation was significantly slower in G␣ q than in NTG myocytes, although I Ca density was not altered (30) . It is therefore possible that slower I Ca inactivation may also contribute to action potential prolongation in G␣ q myocytes. The possible contribution of this effect to action potential prolongation was tested with BAPTA (10 mM) used as an intracellular Ca 2ϩ buffer to minimize Ca 2ϩ -dependent I Ca inactivation (19, 24, 25) . In NTG myocytes, action potential duration was significantly longer in the presence of BAPTA than without an intracellular Ca 2ϩ buffer. The APD 50 and APD 70 were 27.8 Ϯ 1.4 and 37.7 Ϯ 2.1 ms (n ϭ 11), respectively.
We next tested whether a reduction of I to alone is sufficient to account for the changes in action potential duration, then pharmacological inhibition of I to by 4-AP in NTG myocytes should reproduce the action potential phenotype observed in G␣q myocytes. To address this question, we measured APD 50 and APD 70 in NTG myocytes after application of 4-AP (100 M) to reduce I to by ϳ40% (Fig. 3C) . Although 4-AP prolonged action potential duration in NTG myocytes, action potential duration was still significantly shorter than in G␣ q myocytes: APD 50 before and after 4-AP was 13.5 Ϯ 1.0 and 18.5 Ϯ 2.0 ms, and APD 70 before and after 4-AP was 16.7 Ϯ 1.9 and 24.8 Ϯ 3.3 ms (n ϭ 7), respectively.
Furthermore, when action potentials were compared in the presence of a higher concentration of 4-AP (2 mM), action potential duration became significantly longer in G␣ q than in NTG myocytes (Fig. 7) . These measures of APD 50 and APD 70 are summarized in Table 2 . Taken together, these data indicate that a decreased I to expression may contribute to the action potential prolongation observed in G␣ q myocytes. However, additional changes, including a slower I Ca inactivation, may also participate in the overall changes in action potential duration.
␤-AR signaling: effects of Iso and forskolin on I Ca . To minimize Ca 2ϩ -dependent inactivation and subsequent negative ␤-AR regulation of the Ca 2ϩ channels, myocytes were dialyzed with BAPTA (24, 25) . As in our previous study (30) , the peak I Ca densities in NTG and G␣q myocytes were similar: 13.4 Ϯ 0.7 (n ϭ 36) and 12.3 Ϯ 0.8 pA/pF (n ϭ 32), respectively. When I Ca inactivation was measured in myocytes dialyzed with Fig. 6 . Determination of Na ϩ /Ca 2ϩ exchanger (NCX-1) gene transcript levels in NTG and G␣ q hearts. Total RNA was isolated from hearts of G␣ q (G) mice (n ϭ 5) and NTG (N) littermates (n ϭ 5). A portion (5 g) of each RNA sample was hybridized with a riboprobe specific for the mouse NCX-1 gene. The reaction mixture was treated with RNase, electrophoresed on a 5% denaturing gel, and visualized after a 24-h exposure to X-ray film (A). C: quantification of NCX-1 levels. * Significantly different (P Ͻ 0.01) from NTG hearts. To demonstrate that equivalent levels of RNA were analyzed, 2-g aliquots of the G␣ q and NTG cardiac RNA were electrophoresed and visualized (B). EGTA (30) , the time to half-decay was significantly slower in G␣ q myocytes (30.9 Ϯ 1.6 ms, n ϭ 30) than in NTG myocytes (18.5 Ϯ 1.8 ms, n ϭ 29). However, with BAPTA, the mean times to half-decay were similar: 44.2 Ϯ 2.4 (n ϭ 10) and 44.4 Ϯ 3.4 ms (n ϭ 8) for NTG and G␣ q myocytes, respectively.
The traces in Fig. 8 show I Ca activated at different membrane potentials in the absence and presence of Iso (1 M). The application of Iso increased I Ca amplitude in both groups; however, the effect of Iso was significantly less in G␣ q myocytes. In these experiments, Iso increased peak I Ca by 160% of basal value in NTG myocytes (Fig. 8A ) but only by 15% in G␣ q myocytes (Fig. 8B) . A negative shift of the I-V relationships was also observed in both groups. When data were fitted to a Boltzmann relationship (see MATERIALS AND METHODS), the shift in the I-V relationship was Ϫ13.1 Ϯ 1.0 and Ϫ4.8 Ϯ 0.7 mV for NTG (n ϭ 15) and G␣ q myocytes (n ϭ 18), respectively. Figure 9A summarizes the cumulative dose-response effects of Iso on peak I Ca . Although EC 50 was similar in both groups (28.9 and 27.4 nM for NTG and G␣ q , respectively), Iso was significantly less effective in G␣ q myocytes. The increase of peak I Ca by Iso (1 M) was 124 Ϯ 13% for NTG and 30 Ϯ 5% for G␣ q myocytes.
The attenuated response of G␣q myocytes to Iso could be due to changes at several levels in the ␤-AR signaling cascade (13) . To test the possibility that loss of response to Iso was caused by reduced adenylyl cyclase activity, we examined the effects of an adenylyl cyclase activator, forskolin. In NTG myocytes, the maximal responses of I Ca to forskolin (5 M) and Iso (1 M) were similar. Furthermore, forskolin did not lead to a further increase of I Ca after maximum I Ca induced by Iso. In contrast, we found that subsequent forskolin application further enhanced I Ca in G␣ q myocytes. However, the combined effect was still significantly less than the effect of Iso in NTG myocytes. Thus the attenuated responsiveness of the G␣ q myocytes to Iso occurs not only at the receptor level but also at or below the adenylyl cyclase level. To test this hypothesis, we compared the effects of forskolin (5 M) on I Ca in NTG and G␣ q myocytes. As shown in Fig. 9B , forskolin increased I Ca by 125 Ϯ 21% in NTG myocytes (n ϭ 17), whereas the stimulatory effect was significantly less in G␣ q myocytes (67 Ϯ 6%, n ϭ 25).
Previous studies in animal models of hypertrophy as well as those in human heart failure indicate a change in G protein expression levels (13) . To test possible involvement of G i in ␤-AR regulation of I Ca , we measured effects of Iso and forskolin in G␣q myocytes after incubation with PTX (2 g/ml for 4-6 h). The effect of PTX treatment was evaluated by testing the effects of carbachol (10 M) on the activation of muscarinic K ϩ currents in atrial myocytes. Figure 10A shows, as expected, carbachol-activated K ϩ currents in an untreated atrial myocyte. In contrast, the activation was completely abolished in cells treated with PTX. Despite such a pretreatment, G␣ q myocytes continue to show significantly reduced responses to Iso (Fig. 10B) . Maximal Iso (1 M)-stimulated increases in I Ca in PTXtreated myocytes were 122 Ϯ 17 and 17 Ϯ 8% over baseline in NTG and G␣ q myocytes, respectively.
DISCUSSION
In the present study, we found that myocytes isolated from G␣ q hearts exhibit prolonged action poten- Values are means Ϯ SE expressed in ms. 4-AP was administered at 2 mM. * P Ͻ 0.01 vs. respective control before application of 4-AP. † P Ͻ 0.01 vs. NTG. tials and decreased densities of the repolarizing K ϩ currents (I to and I K1 ). These observations suggest that a common pattern of electrophysiological changes, associated with human heart failure, occurs in this model of cardiac hypertrophy. The data also support the hypothesis that enhanced Ca 2ϩ influx during the prolonged action potential in G␣ q myocytes may compensate for the reduced SR Ca 2ϩ loading to support peak contractions or Ca 2ϩ transients that are otherwise significantly reduced as a result of diminished SR function (30) . Additionally, our data indicate that multiple changes, including a decrease in ␤-AR coupling to adenylyl cyclase and a reduction in the activity of adenylyl cyclase, contribute to the depressed responses of I Ca to Iso. It is possible that catecholamines released by tonic sympathetic activation of cardiac nerves or in the circulation could stimulate ␤-AR, even under basal conditions, and attenuated responsiveness of I Ca to ␤-AR stimulation in G␣ q myocytes may contribute to depressed ventricular dysfunction observed in vivo.
Our experiments demonstrate that action potential duration was significantly prolonged in G␣ q myocytes. APD 50 and APD 70 were prolonged, and these changes were associated with reductions in I to , I K1 , and Na ϩ / Ca 2ϩ exchange current densities. In cardiac myocytes, Ca 2ϩ influx through the L-type Ca 2ϩ channel is the primary pathway to trigger Ca 2ϩ release from the SR. However, prolongation of the action potential may result in an enhanced inward Ca 2ϩ influx and SR Ca 2ϩ loading to support contractility in G␣ q myocytes. The most prominent electrophysiological abnormality found in a variety of experimental models of heart failure as well as human heart failure is action potential prolongation. The duration of the cardiac action potential is controlled by a balance of inward and outward currents. As in human ventricular myocytes, I to are present in adult ventricular myocytes and are responsible for the repolarization phase of the action potential (27, 31) . It is therefore likely that a decrease in I to contributes to changes in the action potential in G␣ q myocytes. Consistent with this notion, 4-AP prolonged the action potential duration in NTG cells, but 4-AP prolonged the action potential more in G␣ q than in NTG myocytes. These results indicate that a change in I to alone is not sufficient to account for the action potential profile observed in G␣ q myocytes. Similar results, i.e., that 4-AP prolongs action potential more dramatically in myocytes from failing hearts than in normal myocytes, have been reported previously (14) .
Because I K1 is responsible for the terminal phase of repolarization, it is possible that a decrease in I K1 may also contribute to some of the prolongation of the terminal phase of the action potential (14, 28) . Many factors affect the Na ϩ /Ca 2ϩ exchange activity, including membrane potential and internal and external Na ϩ and Ca 2ϩ (6) . It is therefore difficult to predict the extent to which action potential duration is altered by decreasing Na ϩ /Ca 2ϩ exchange in G␣ q myocytes. However, it is unlikely that the reduction of this current played a significant role in the action potential prolongation found in G␣ q myocytes. An alternative explanation for the prolonged action potential would be a reduced Ca 2ϩ -dependent inactivation. We previously demonstrated that G␣ q myocytes exhibit significantly slower I Ca inactivation due to impaired SR function and/or a defective I Ca -induced SR Ca 2ϩ release process (30) . It is therefore likely that slower I Ca inactivation associated with altered cellular Ca 2ϩ handling contributes to the action potential prolongation in G␣ q myocytes. A modulatory role of increased Ca 2ϩ influx as a result of reduced Ca 2ϩ -dependent inactivation in the plateau phase of the action potential has been reported in the failing heart by computer model analysis (28) .
It has been reported that Na ϩ /Ca 2ϩ exchange activity is increased in failing hearts (17, 22) . In failing hearts with significantly impaired SR Ca 2ϩ removal, enhanced Na ϩ /Ca 2ϩ exchange activity during the Ca 2ϩ transients may be an important compensatory mechanism. However, in our study, which uses a relatively compensated form of hypertrophy (23), we found that Na ϩ /Ca 2ϩ exchange current activity and expression of the NCX-1 gene were reduced. In G␣ q hearts the SR Ca 2ϩ uptake rate was reduced by ϳ30% (30) . Therefore, the decrease in NCX-1 expression cannot serve to compensate for defective SR Ca 2ϩ uptake. The cause of this difference is not known. It is possible that the decrease in NCX-1 may serve to compensate for a different Ca 2ϩ pathway or result from a noncompensatory inhibition of NCX-1 gene transcript by a G␣ q -mediated signaling pathway. Future studies of a direct comparison of Na ϩ /Ca 2ϩ exchanger function at various stages of cardiac hypertrophy and failure in the same model would permit establishment of the functional roles mediated by changes in Na ϩ /Ca 2ϩ exchanger activity.
Our data show that Iso increased I Ca in NTG and G␣ q myocytes with similar affinity, but the magnitude of the response to the drug was significantly reduced in G␣ q myocytes. ␤-AR-mediated increases in I Ca depend on the ␤-AR signaling cascade. Because ␤-AR density was found to be normal in the G␣ q heart (8), the reduced response to Iso in G␣ q myocytes suggests potential changes in ␤-AR and Ca 2ϩ channel coupling. In NTG myocytes, maximal activation of I Ca with Iso or forskolin was similar, and such activation was not additive. In contrast, although the relative increase in I Ca with forskolin was still significantly less in G␣ q than in NTG myocytes, forskolin was capable of activating I Ca more potently than Iso. Pretreatment of cells with PTX did not alter the I Ca responses to Iso or forskolin. We previously demonstrated that the responses of I Ca to dihydropyridine drugs and a membrane-permeable cAMP analog, 8-(4-chlorophenylthio)-cAMP, were not altered in G␣ q myocytes, suggesting that modulation of the Ca 2ϩ channel by cAMP-dependent protein kinase A activation is normal (30) . Taken together, our data suggest that impaired ␤-AR-adenylyl cyclase coupling and reduced adenylyl cyclase activity are involved in the reduced responsiveness of I Ca to Iso. The electrophysiological observations are consistent with biochemical observations that basal and forskolin-activated adenylyl cyclase activities in G␣q hearts were reduced by ϳ45% compared with NTG hearts (26) .
In summary, we have studied electrophysiological properties that may contribute to altered Ca 2ϩ handling and ␤-AR regulation of I Ca in a genetic model of cardiac hypertrophy. The hypertrophy-associated action potential prolongation is a prominent feature of G␣ q myocytes. Our data suggest that multiple changes in the ␤-AR signaling pathway that regulates I Ca occur in G␣ q myocytes. Because the signal transduction pathway mediated by G␣ q is closely associated with the induction of cardiac hypertrophy and the progression of heart failure (1, 2, 8, 20, 23) , this transgenic model may serve as an informative model system for understanding the cellular mechanisms of heart failure in humans.
